Skip to content

Author

M. Herlyn

We have 1 of 697 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

TFAP2A links drug resistance to antitumor immunity

This work found that BRAF/MEK inhibitors significantly upregulate TFAP2A, and identifies TFAP2A as a shared driver of both targeted therapy resistance and immunosuppression, offering a one-stone-two-bird strategy to overcome drug resistance and elicit antitumor immunity.

Haiwei Mou, Veronika Yakovishina, Kristen M DeRosa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.